View Item 

Show simple item record

Baseline Leptin Levels Predict Change in Leptin Levels During Weight Loss in Obese Breast Cancer Survivors
dc.contributor.authorSen, Anandaen_US
dc.contributor.authorJen, Kai-Lin Catherineen_US
dc.contributor.authorDjuric, Zoraen_US
dc.date.accessioned2010-06-01T19:55:18Z
dc.date.available2010-06-01T19:55:18Z
dc.date.issued2007-03en_US
dc.identifier.citationSen, Ananda; Jen, Kai-Lin Catherine; Djuric, Zora (2007). "." The Breast Journal 13(2): 180-186. <http://hdl.handle.net/2027.42/73051>en_US
dc.identifier.issn1075-122Xen_US
dc.identifier.issn1524-4741en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73051
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17319860&dopt=citationen_US
dc.format.extent508765 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 Blackwell Publishing, Inc.en_US
dc.subject.otherBreast Canceren_US
dc.subject.otherLeptinen_US
dc.subject.otherObesityen_US
dc.subject.otherWeight Lossen_US
dc.titleBaseline Leptin Levels Predict Change in Leptin Levels During Weight Loss in Obese Breast Cancer Survivors
dc.typeArticleen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum* Department of Family Medicine, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Nutrition and Food Science, Wayne State University, Detroit, Michiganen_US
dc.identifier.pmid17319860en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73051/1/j.1524-4741.2007.00397.x.pdf
dc.identifier.doi10.1111/j.1524-4741.2007.00397.xen_US
dc.identifier.sourceThe Breast Journalen_US
dc.identifier.citedreferenceBray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006; 29: 109 – 17.en_US
dc.identifier.citedreferenceChlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002; 20: 1128 – 43.en_US
dc.identifier.citedreferenceKroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005; 23: 1370 – 8.en_US
dc.identifier.citedreferenceEnger SM, Greif JM, Polikoff J, Press M. Body weight correlates with mortality in early-stage breast cancer. Arch Surg 2004; 139: 954 – 58.en_US
dc.identifier.citedreferenceLoi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1686 – 91.en_US
dc.identifier.citedreferenceDaling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001; 92: 720 – 9.en_US
dc.identifier.citedreferenceDignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003; 95: 1467 – 76.en_US
dc.identifier.citedreferenceHarvie MN, Campbell IT, Baildam A, Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 2004; 83: 201 – 10.en_US
dc.identifier.citedreferenceWilmoth MC, Coleman EA, Smith SC, Davis C. Fatigue, weight gain, and altered sexuality in patients with breast cancer: exploration of a symptom cluster. Oncol Nurs Forum 2004; 31: 1069 – 75.en_US
dc.identifier.citedreferenceDemark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001; 19: 2381 – 9.en_US
dc.identifier.citedreferenceIrwin ML, McTiernan A, Baumgartner RN, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 2005; 23: 774 – 82.en_US
dc.identifier.citedreferenceGoodwin PJ, Ennis M, Pritchard KI, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 1999; 17: 120 – 9.en_US
dc.identifier.citedreferenceFreedman RJ, Aziz N, Albanes D, et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab 2004; 89: 2248 – 53.en_US
dc.identifier.citedreferenceDemark-Wahnefried W, Rimer B, Winer E. Weight gain in women diagnosed with breast cancer. J Am Dietetic Assoc 1997; 97: 519 – 26.en_US
dc.identifier.citedreferenceRock CL, Demark-Wahnefried W. Can lifestyle modification increase survival in women diagnosed with breast cancer ? J Nutr 2002; 132: 3504S – 7S.en_US
dc.identifier.citedreferenceGoodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002; 20: 42 – 51.en_US
dc.identifier.citedreferenceAydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem 2001; 34: 65 – 70.en_US
dc.identifier.citedreferenceSaintot M, Mathieu-Daude H, Astre C, Grenier J, Simony-Lafontaine J, Gerber M. Oxidant-antioxidant status in relation to survival among breast cancer patients. Int J Cancer 2002; 97: 574 – 9.en_US
dc.identifier.citedreferenceRose DP, Gilhooly EM, Nixon DW. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin. Int J Oncol 2002; 21: 1285 – 92 ( review ).en_US
dc.identifier.citedreferenceHan C, Zhang HT, Du L, et al. Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 2005; 26: 19 – 24.en_US
dc.identifier.citedreferenceGoodwin PJ, Ennis M, Fantus IG, et al. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer ? J Clin Oncol 2005; 23: 6037 – 42.en_US
dc.identifier.citedreferenceChen DC, Chung YF, Yeh YT, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 2006; 237: 109 – 14.en_US
dc.identifier.citedreferenceGarofalo C, Sisci D, Surmacz E. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 2004; 10: 6466 – 75.en_US
dc.identifier.citedreferenceMiyoshi Y, Funahashi T, Tanaka S, et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006; 118: 1414 – 9.en_US
dc.identifier.citedreferenceKaur T, Zhang ZF. Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev 2005; 6: 547 – 52.en_US
dc.identifier.citedreferenceRose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004; 5: 153 – 65.en_US
dc.identifier.citedreferenceSulkowska M, Golaszewska J, Wincewicz A, Koda M, Baltaziak M, Sulkowski S. Leptin – from regulation of fat metabolism to stimulation of breast cancer growth. Pathol Oncol Res 2006; 12: 69 – 72.en_US
dc.identifier.citedreferenceMiyoshi Y, Funahashi T, Tanaka S, et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006; 118: 1414 – 9.en_US
dc.identifier.citedreferenceJequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002; 967: 379 – 88.en_US
dc.identifier.citedreferenceTessitore L, Vizio B, Jenkins O, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421 – 6.en_US
dc.identifier.citedreferenceStattin P, Soderberg S, Biessy C, et al. Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 2004; 86: 191 – 6.en_US
dc.identifier.citedreferenceChen DC, Chung YF, Yeh YT, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 2006; 237: 109 – 14.en_US
dc.identifier.citedreferenceMantzoros CS, Bolhke K, Moschos S, Cramer DW. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer 1999; 80: 523 – 6.en_US
dc.identifier.citedreferenceOzet A, Arpaci F, Yilmaz MI, et al. Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 2001; 31: 424 – 7.en_US
dc.identifier.citedreferenceFalk RT, Brinton LA, Madigan MP, et al. Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 2006; 98: 157 – 65.en_US
dc.identifier.citedreferenceJen KL, Djuric Z, DiLaura NM, et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obes Res 2004; 12: 306 – 12.en_US
dc.identifier.citedreferenceCaldefie-Chezet F, Damez M, de Latour M, et al. Leptin: A proliferative factor for breast cancer. Study on human ductal carcinoma Biochem Biophys Res Commun 2005; 334: 737 – 41.en_US
dc.identifier.citedreferenceOkumura M, Yamamoto M, Sakuma H, et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 2002; 1592: 107.en_US
dc.identifier.citedreferenceDieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R, Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2002; 293: 622 – 8.en_US
dc.identifier.citedreferenceHu X, Juneja SC, Maihle NJ, Cleary MP. Leptin – a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002; 94: 1704 – 11.en_US
dc.identifier.citedreferenceNiskanen LK, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MI. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. Eur J Endocrinol 1997; 137: 61 – 7.en_US
dc.identifier.citedreferenceVerdich C, Toubro S, Buemann B, et al. Leptin levels are associated with fat oxidation and dietary-induced weight loss in obesity. Obes Res 2001; 9: 452 – 61.en_US
dc.identifier.citedreferenceBobbioni-Harsch E, Assimacopoulos-Jeannet F, Lehmann T, Munger R, Allaz AF, Golay A. Leptin plasma levels as a marker of sparing-energy mechanisms in obese women. Int J Obes Relat Metab Disord 1999; 23: 470 – 5.en_US
dc.identifier.citedreferenceDjuric Z, DiLaura NM, Jenkins I, et al. Combining weight-loss counseling with the Weight Watchers plan for obese breast cancer survivors. Obes Res 2002; 10: 657 – 65.en_US
dc.identifier.citedreferenceFrisard MI, Greenway FL, Delany JP. Comparison of methods to assess body composition changes during a period of weight loss. Obes Res 2005; 13: 845 – 54.en_US
dc.identifier.citedreferenceMarttunen MB, Andersson S, Hietanen P, et al. Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients. Maturitas 2000; 35: 175 – 9.en_US
dc.identifier.citedreferenceRuhl CE, Everhart JE. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr 2001; 74: 295 – 301.en_US
dc.identifier.citedreferenceWadden TA, Considine RV, Foster GD, Anderson DA, Sarwer DB, Caro JS. Short- and long-term changes in serum leptin dieting obese women: effects of caloric restriction and weight loss. J Clin Endocrinol Metab 1998; 83: 214 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1524-4741.2007.00397.x.pdf
Size:
496.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.